600851.SHG Shanghai Haixin Group Co Ltd A
- Market cap
- CNY 10.9B
- P/E
- 56.6x
- P/B
- 2.22x
- ROE
- 4.4%
- Dividend yield
- 0.45%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 600851.SHG undervalued?
Graham number600851.SHG trades 136.0% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Shanghai Haixin Group Co Ltd A fundamental analysis
No fundamental analysis for Shanghai Haixin Group Co Ltd A yet.
Shanghai Haixin Group Co Ltd A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Shanghai Haixin Group Co Ltd A
Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of industrial park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics and clothing. The company also offers property and value-added services. Shangh…
Full company profileShanghai Haixin Group Co Ltd A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Shanghai Haixin Group Co Ltd A annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.01B | 1.00B | 1.10B | 1.11B | 933M | 1.51B | 1.44B | 1.18B | 796M | 758M | 641M |
| Gross Profit | 140M | 300M | 441M | 454M | 422M | 617M | 653M | 544M | 444M | 449M | 397M |
| Operating Income | 59.2M | 123M | 183M | 142M | 108M | 112M | 230M | 211M | 179M | 45.3M | 49.4M |
| EBITDA | 102M | 154M | 213M | 166M | 138M | 134M | 257M | 233M | 203M | 226M | 247M |
| Net Income | 90.0M | 105M | 135M | 104M | 119M | 132M | 164M | 166M | 151M | 176M | 212M |
| EPS | 0.07 | 0.09 | 0.11 | 0.09 | 0.10 | 0.11 | 0.14 | 0.14 | 0.13 | 0.15 | 0.18 |
| Balance Sheet | |||||||||||
| Total Assets | 5.43B | 4.89B | 4.51B | 5.16B | 5.63B | 5.33B | 4.93B | 4.91B | 5.33B | 5.84B | 5.89B |
| Total Liabilities | 1.09B | 942M | 884M | 1.11B | 1.25B | 1.04B | 911M | 775M | 830M | 925M | 907M |
| Shareholders' Equity | 4.15B | 3.78B | 3.42B | 3.85B | 4.19B | 4.13B | 3.84B | 3.97B | 4.33B | 4.72B | 4.78B |
| Cash & Short-term Investments | 526M | 511M | 457M | 395M | 524M | 561M | 715M | 710M | 770M | 384M | 424M |
| Total Debt | 146M | 119M | 160M | 227M | 216M | 20.1M | 28.3M | 37.1M | 25.0M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -19.8M | 13.3M | 55.5M | -26.0M | 122M | 220M | 73.6M | -35.9M | 77.5M | 118M | - |
| Capital Expenditure | 55.3M | 85.5M | 106M | 239M | 155M | 74.0M | 15.9M | 61.8M | 29.7M | 117M | 52.8M |
| Free Cash Flow | -75.1M | -72.2M | -50.7M | -265M | -32.4M | 146M | 57.6M | -97.6M | 47.8M | 586K | -106M |
| Ratios | |||||||||||
| ROE | 2.2% | 2.8% | 4.0% | 2.7% | 2.9% | 3.2% | 4.3% | 4.2% | 3.5% | 3.7% | 4.4% |
| ROA | 1.7% | 2.2% | 3.0% | 2.0% | 2.1% | 2.5% | 3.3% | 3.4% | 2.8% | 3.0% | 3.6% |
| Net Profit Margin | 8.9% | 10.5% | 12.3% | 9.3% | 12.8% | 8.7% | 11.4% | 14.0% | 19.0% | 23.2% | 33.0% |
| Debt to Equity | 0.04x | 0.03x | 0.05x | 0.06x | 0.05x | 0.00x | 0.01x | 0.01x | 0.01x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Shanghai Haixin Group Co Ltd A dividends
- Dividend yield
- 0.45%
- Forward dividend
- 0.05 CNY
- Payout ratio
- 27.8%
- Ex-dividend date
- Jul 24, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 49.0M | 0.04 | 27.8% |
| 2024 | CNY 79.4M | 0.07 | 52.6% |
| 2023 | CNY 55.5M | 0.05 | 33.4% |
| 2022 | CNY 42.2M | 0.03 | 25.8% |
| 2021 | CNY 36.2M | 0.03 | 27.4% |
| 2020 | CNY 36.2M | 0.03 | 30.3% |
| 2019 | CNY 42.2M | 0.03 | 40.6% |
| 2018 | CNY 41.6M | 0.03 | 30.8% |
| 2017 | CNY 33.5M | 0.03 | 31.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Jun 8, 2005.
Who owns Shanghai Haixin Group Co Ltd A
- Insiders 43.26%
- Institutions 14.29%
- Public & others 42.45%
- Shares outstanding 738M
- Free float 885M
Shanghai Haixin Group Co Ltd A company profile
- Company name
- Shanghai Haixin Group Co Ltd A
- Ticker
- 600851.SHG
- ISIN
- CNE000000CF1
- Exchange
- Shanghai Stock Exchange
- Listed since
- Oct 10, 1993
- Sector
- Industrials
- Industry
- Pharmaceuticals
- Employees
- 675
- Fiscal year end
- December
- Address
- Huaxin Haixin Building, Shanghai, China, 200001
- Phone
- 86 21 6391 7000
- Website
- haixin.com.cn
About Shanghai Haixin Group Co Ltd A
Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of industrial park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics and clothing. The company also offers property and value-added services. Shanghai Haixin Group Co., Ltd. was founded in 1986 and is headquartered in Shanghai, China.
Shanghai Haixin Group Co Ltd A management
8- Mr. Xiaowei RenPresident · born 1972
- Mr. Xifeng ZhuCFO & Financial Director · born 1977
- Mr. Gao ZhangSecretary to the Board · born 1990
- Mr. Jianming TaoVice President · born 1969
- Ms. Xiao Cen ZhouVice President · born 1990
- Mr. Biao XiongVice President · born 1988
- Mr. Yu Dong LinVice President · born 1973
- Jian Hong YanAccounting Supervisor